263 related articles for article (PubMed ID: 20401594)
1. Measuring the activity of active efflux in gram-negative bacteria.
Webber MA; Coldham NG
Methods Mol Biol; 2010; 642():173-80. PubMed ID: 20401594
[TBL] [Abstract][Full Text] [Related]
2. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
Nikaido H; Pagès JM
FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
[TBL] [Abstract][Full Text] [Related]
3. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
Blair JM; Richmond GE; Piddock LJ
Future Microbiol; 2014; 9(10):1165-77. PubMed ID: 25405886
[TBL] [Abstract][Full Text] [Related]
4. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
[TBL] [Abstract][Full Text] [Related]
5. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists.
Aeschlimann JR
Pharmacotherapy; 2003 Jul; 23(7):916-24. PubMed ID: 12885104
[TBL] [Abstract][Full Text] [Related]
6. Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier.
Zgurskaya HI; Rybenkov VV; Krishnamoorthy G; Leus IV
Res Microbiol; 2018; 169(7-8):351-356. PubMed ID: 29454787
[TBL] [Abstract][Full Text] [Related]
7. Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods.
Laudy AE
Pol J Microbiol; 2018 Jun; 67(2):129-135. PubMed ID: 30015451
[TBL] [Abstract][Full Text] [Related]
8. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
9. New Multidrug Efflux Inhibitors for Gram-Negative Bacteria.
Marshall RL; Lloyd GS; Lawler AJ; Element SJ; Kaur J; Ciusa ML; Ricci V; Tschumi A; Kühne H; Alderwick LJ; Piddock LJV
mBio; 2020 Jul; 11(4):. PubMed ID: 32665275
[TBL] [Abstract][Full Text] [Related]
10. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
[TBL] [Abstract][Full Text] [Related]
11. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
Wang Y; Venter H; Ma S
Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
Vila J; Martínez JL
Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
[TBL] [Abstract][Full Text] [Related]
13. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
[TBL] [Abstract][Full Text] [Related]
14. [Significance of efflux pumps in multidrug resistance of Gram-negative bacteria].
Wiercińska O; Chojecka A; Kanclerski K; Rőhm-Rodowald E; Jakimiak B
Med Dosw Mikrobiol; 2015; 67(1):55-62. PubMed ID: 26084076
[TBL] [Abstract][Full Text] [Related]
15. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
Li XZ; Plésiat P; Nikaido H
Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
[TBL] [Abstract][Full Text] [Related]
16. The role of efflux pumps ın antıbıotıc resıstance of gram negatıve rods.
Başaran SN; Öksüz L
Arch Microbiol; 2023 Apr; 205(5):192. PubMed ID: 37060362
[TBL] [Abstract][Full Text] [Related]
17. The development of efflux pump inhibitors to treat Gram-negative infections.
Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
[TBL] [Abstract][Full Text] [Related]
18. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
Pagès JM; Amaral L; Fanning S
Curr Med Chem; 2011; 18(19):2969-80. PubMed ID: 21651484
[TBL] [Abstract][Full Text] [Related]
19. Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.
Duffey M; Jumde RP; da Costa RMA; Ropponen HK; Blasco B; Piddock LJV
ACS Infect Dis; 2024 May; 10(5):1458-1482. PubMed ID: 38661541
[TBL] [Abstract][Full Text] [Related]
20. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.
Lomovskaya O; Bostian KA
Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]